Analgesics (Pharmacies) - Northern Europe

  • Northern Europe
  • Revenue in the Analgesics market is projected to reach US$0.36bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.48%, resulting in a market volume of US$0.47bn by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$10.52 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Northern Europe is experiencing steady growth and development.

Customer preferences:
Customers in Northern Europe have a strong preference for over-the-counter analgesics, which can be easily purchased at pharmacies without a prescription. This preference is driven by the convenience and accessibility of these products. Additionally, customers in this region tend to value natural and organic ingredients in their analgesics, as they prioritize health and wellness.

Trends in the market:
One trend in the Analgesics (Pharmacies) market in Northern Europe is the increasing demand for non-opioid analgesics. This trend is driven by a growing awareness of the risks and side effects associated with opioid use, as well as a desire for safer and more natural alternatives. Customers in this region are increasingly seeking out non-opioid options, such as NSAIDs and acetaminophen, for pain relief. Another trend in the market is the rising popularity of online pharmacies. Customers in Northern Europe are increasingly turning to online platforms to purchase their analgesics. This trend is driven by the convenience and ease of online shopping, as well as the availability of a wide range of products. Online pharmacies also often offer competitive prices and discounts, which further attracts customers.

Local special circumstances:
One special circumstance in the Analgesics (Pharmacies) market in Northern Europe is the strong emphasis on healthcare and wellness. Countries in this region have robust healthcare systems and prioritize the well-being of their citizens. This emphasis on health and wellness extends to the analgesics market, with customers seeking out products that are safe, effective, and promote overall well-being. Another special circumstance is the strict regulations and quality standards in place for pharmaceutical products. Northern European countries have rigorous regulatory frameworks that ensure the safety and efficacy of analgesics sold in pharmacies. This gives customers confidence in the products they purchase and contributes to the overall growth and development of the market.

Underlying macroeconomic factors:
The growth and development of the Analgesics (Pharmacies) market in Northern Europe can be attributed to several underlying macroeconomic factors. Firstly, the region has a high disposable income, which allows customers to afford and prioritize healthcare products. Additionally, the aging population in Northern Europe is driving the demand for analgesics, as older individuals tend to experience more pain and require pain relief medications. Furthermore, the increasing prevalence of chronic diseases, such as arthritis and back pain, is also contributing to the growth of the market. As the incidence of these conditions rises, so does the demand for analgesics to manage pain symptoms. This creates a steady and consistent market for analgesics in Northern Europe. In conclusion, the Analgesics (Pharmacies) market in Northern Europe is developing due to customer preferences for over-the-counter products, the increasing demand for non-opioid analgesics, the rising popularity of online pharmacies, the emphasis on healthcare and wellness, as well as underlying macroeconomic factors such as high disposable income, an aging population, and the prevalence of chronic diseases.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)